Finished
OPERA - Incorporating Robotic Surgery in Both Mastectomy and DIEP Flap Reconstruction
NCT06415526 · Chang Gung Memorial Hospital · Updated 16 May 2024
- What is being tested
- OPERA
- For
- Breast Cancer; Mastectomy; Lymphedema
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 80 years. About 14 people. The full rules are on the registry page.
- Where
- Taiwan
- When
- Starts or started 3 May 2024, ends 10 May 2024. Registered 16 May 2024.
- Results
- None posted yet.
In the researchers' words
Current breast cancer surgery is achieving minimally invasive approach to reduce incision while providing better surgical vision and freedom in mastectomy. Breast reconstruction with free deep inferior epigastric artery perforator (DIEP) flap was considered the gold standard, however, the donor site morbidity remains an endless concern. Here we applied robotic-assisted surgery in both mastectomy and free DIEP flap harvest, so-called Oncoplastic Entirely Robot-Assisted Approach (OPERA). A retrospective chart review identified 14 patients with unilateral breast cancer received robotic-assisted mastectomy and robotic assisted free DIEP flap harvest for breast reconstruction. The patient demographics and mastectomy and flap characteristics were reviewed.
Sites
- Chang Gung Memorial HospitalTaoyuan, Taiwan